Developing a Direct to Patient Shipment Strategy: Part 1 of 2

Developing a Direct to Patient Shipment Strategy:

Part 1 of a 2-Part Panel Series

A panel of clinical trial sponsor and distribution partner representatives – all with experience in direct-to-patient shipments – will review what is possible to achieve and what constraints may be encountered when considering DtP for clinical trials. We’ll also hear from the most important clinical trial stakeholder, a patient who has experienced the shift from in-clinic visits to treatment delivered at their doorstep; he will share his perspective as it relates to the development of a DtP clinical trial strategy.

Learn more about Part 2 in the series

October 5, 2021


Sylvain Berthelot image

Sylvain Berthelot

Director, Solution Consultant, Calyx (Moderator)

Sylvain has acquired extensive experience in IRT through various roles within Calyx over his 10+ years in the company. It allows him to grasp where IRT can make a difference based on the protocol design, and accordingly advise clinical trial teams what solution is the most suitable for each trial. Sylvain is a key member of the Calyx IRT product core team, acting as an advocate for end-users, as well as sharing his vision with the team to push the boundaries of IRT.

Nicole Gray image

Nicole Gray

Director, Strategic Supply Solutions, Catalent

Nicole Gray is currently Director, Strategic Supply Solutions for Catalent Clinical Supply Services, responsible for developing the Direct to Patient business and other new strategic service offerings. She has been in the Pharmaceutical industry for 18 years and has held multiple roles in clinical supplies project management. Prior to moving to her current role in August 2018, Nicole spent 6 years as the Director of Project Management for the Catalent Philadelphia site, responsible for a team of 45 Project Coordinators, Project Managers, and Sr. Project Managers. Prior to moving to Catalent Philadelphia, Nicole was responsible for the Mt. Laurel and Allendale Project Management teams (previously Aptuit).

Prior to joining Catalent, Nicole held various project management, communications, and marketing coordination roles at Omnicare Clinical Research, GE Financial Assurance, and the United States House of Representatives.

Nicole is an active member of the Global Clinical Supplies Group (GCSG). She is currently the Vice Chair for the 2022 US Conference and previously held both the US Conference Secretary & Board Secretary roles.

Kristy Jackson-Addie image

Kristy Jackson-Addie

Distribution Design Lead, AstraZeneca

Kirsty Jackson-Addie is the Distribution Design Lead within Global Clinical Supply Chain at AstraZeneca, based in Macclesfield UK. She has 20+ years of experience in the pharmaceutical industry and has held scientific operational management and supply chain management positions. In her current role, Kirsty has responsibility for delivering optimized distribution strategies to support complex clinical trial designs and leading end-to-end supply chain improvement projects. She has a particular interest in developments in tools and technologies aiming to facilitate distribution solutions. Kirsty is an APICS Certified Supply Chain Professional and has an MSc. in Instrumental and Process Analytical Chemistry from the University of Strathclyde, UK

Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

  • This field is for validation purposes and should be left unchanged.